AnaptysBio Inc. – Material Contracts Watch

EX-10.1

from 8-K 3 pages Amendment No. 1 to the Anaptysbio, Inc. Amended and Restated 2017 Equity Incentive Plan August 11, 2026

12/34/56

EX-10.4

from 10-Q 11 pages Certain Personal Information in This Exhibit, Marked by [*], Has Been Redacted Pursuant to Item 601(a)(6) of Regulation S-K. March 26, 2026

12/34/56

EX-10.3

from 10-Q 11 pages Certain Personal Information in This Exhibit, Marked by [*], Has Been Redacted Pursuant to Item 601(a)(6) of Regulation S-K. March 26, 2026

12/34/56

EX-10.2

from 10-Q 9 pages Certain Personal Information in This Exhibit, Marked by [*], Has Been Redacted Pursuant to Item 601(a)(6) of Regulation S-K. Consulting Agreement

12/34/56

EX-10.1

from 10-Q 9 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Would Likely Cause Cmpetitive Harm to Anabtysbio, Inc. if Publicly Disclosed

12/34/56

EX-10.1

from 8-K 26 pages Transition Services Agreement Between First Tracks Biotherapeutics, Inc. and Anaptysbio, Inc. Dated April 20, 2026

12/34/56

EX-10.2

from 8-K 22 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 45 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 21 pages Material contract

12/34/56

EX-10.22

from 10-Q 51 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That Anaptysbio, Inc. Treats as Private or Confidential. Execution Version Exclusive License Agreement by and Between Anaptysbio, Inc. and Vanda Pharmaceuticals Inc. January 31, 2025

12/34/56

EX-10.21

from 10-K 14 pages Material contract

12/34/56

EX-10.29

from 10-Q 15 pages Certain Confidential Information Contained in This Document,marked by [***], Has Been Omitted Because It Is Not Material and Is the Type That Anaptysbio, Inc. Treats as Private or Confidential. Agreement and Amendment No. 1 to the Royalty Purchase Agreement

12/34/56

EX-10.1

from 8-K 21 pages Material contract

12/34/56

EX-10.28

from 10-Q 4 pages Material contract

12/34/56

EX-10.19

from 10-K 6 pages Material contract

12/34/56

EX-10.18

from 10-K 44 pages Material contract

12/34/56

EX-10.27

from 10-Q 18 pages Material contract

12/34/56

EX-10.26

from 10-Q 8 pages Delaware the First State Page 1 4062359 8100 Authentication: 203663607 Sr# 20232896198 Date: 06-30-23 You May Verify This Certificate Online at CORP.DELAWARE.GOV/AUTHVER.SHTML I, Jeffrey W. Bullock, Secretary of State of the State of Delaware, Do Hereby Certify the Attached Is a True and Correct Copy of the Restated Certificate of “Anaptysbio, Inc.”, Filed in This Office on the Twenty-Ninth Day of June, A.D. 2023, at 7:21 O`clock P.M

12/34/56

EX-10.25

from 10-Q 14 pages Material contract

12/34/56

EX-10.24

from 10-Q 41 pages Material contract

12/34/56